Seaport Therapeutics (“Seaport” or the “Company ... All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely ...

After emerging from the shadows with a $100 million Series A in April, Seaport Therapeutics has moved ... Seaport said the money would support a pipeline of improved neuropsychiatric drug ...

Winners include Metsera, COUR Pharmaceuticals, Mirador and Seaport Therapeutics. "This year's NextGen class hits on all the hot areas, from GLP-1s in weight loss to ADCs in cancer and cell therapy ...

The team that brought you Karuna – recently sold to Bristol-Myers Squibb for $14 billion – has set up a neuropsychiatry-focused biotech called Seaport Therapeutics. Karuna co-founder Daphne ...

We look forward to many more moments together as we continue to advance our clinical-stage pipeline and reach our ultimate goal of delivering new medicines that will make a difference in the lives ...

Seaport Therapeutics is a clinical-stage biopharmaceutical company ... All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage ... All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is ...

Seaport Res Ptn analyst G. Chin now anticipates that the company will post earnings of $5.49 per share for the year, down from their prior estimate of $5.50. Seaport Res Ptn has a “Strong-Buy ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team ...

The Badagry Chamber of Commerce, Industry, Mines, and Agriculture has stated that the proposed $2.59bn Badagry Deep Seaport Project could serve as a transshipment hub to landlocked countries if ...

Hexcel Co. (NYSE:HXL – Free Report) – Investment analysts at Seaport Res Ptn decreased their Q3 2025 earnings per share estimates for shares of Hexcel in a report issued on Tuesday ...